← SynDRA
TIPLASININ
SynDRA canonical compound SYN0004270 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | SERPINE1 |
|---|
| Mechanism of action | plasminogen activator inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP3A7
- GPX4
- KSYK
- NTM1A
- NTMT1
- SYK
Cross-references
Synonyms
- Tiplasinine
- Tiplasinina
- PAI-039
- Tiplasinin < USAN
- Tiplaxtinin (formerly)
- 2-[1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl]-2-oxoacetic acid
- Tiplaxtinin
- PAI 039
- tiplasinina
- tiplasinine
- L396QIB983
- PAI039 cpd
- tiplasininum
- RefChem:190105
- DTXCID70115039
- Tiplasinin [USAN]
- PAI-039;Tiplasinin
- MFCD09475615
- Tiplasinin (USAN)
- Tiplaxtinin(PAI-039)
- Tiplasinin [USAN:INN]
- UNII-L396QIB983
- TIPLASININ [INN]
- Tiplaxtinin (PAI-039)
- Tiplaxtinin(PAI-039)?
- MLS006010332
- orb1306703
- SCHEMBL3052065
- SCHEMBL29448190
- C24H16F3NO4
- Tiplaxtinin, >=98% (HPLC)
- EX-A114
- CHEBI:177718
- GLXC-04469
- HMS3740E03
- BDBM50149275
- s7922
- AKOS026750318
Look up TIPLASININ in the interactive SynDRA portal →